The main physiological actions of these agents are discussed, with reference to the immediate infusion-related side effects and complications that may arise from an extravasation injury” Gallimore (2016).
Abstract:
This article provides a comprehensive overview of the risks associated with the administration of chemotherapy, monoclonal antibodies and targeted or biological therapies in the management of solid tumours. The main physiological actions of these agents are discussed, with reference to the immediate infusion-related side effects and complications that may arise from an extravasation injury. The article focuses on the identification and early recognition of these risk factors to implement preventive measures and appropriate management strategies.
[ctt tweet=”ReTweet if useful… Extravasation injury identification and early recognition http://ctt.ec/UCS49+ @ivteam #ivteam” coverup=”UCS49″]
Reference:
Gallimore, E. (2016) Infusion-related risks associated with chemotherapy. Nursing Standard. 30(25), p.51-60.
doi: 10.7748/ns.30.25.51.s48.
Thank you to our partners for supporting IVTEAM
[slideshow_deploy id=’23788’]